Current filters:  
USA
Litigation
Trials & Appeals & Compensation
United States
Katten Muchin Rosenman LLP
In a Citywealth article on the rise in litigation levels in multiple jurisdictions due to financial and geopolitical uncertainties, Partner Joshua Rubenstein, National Chair of Katten's Private Wealth...
Lewis Brisbois Bisgaard & Smith LLP
Los Angeles, Calif. (April 23, 2024) - The California Court of Appeal's decision in Qaadir v. Figueroa (2021) 67 Cal.App.5th 790 ("QAADIR") is an important precedent for personal injury litigation.
Akin Gump Strauss Hauer & Feld LLP
On Earth Day, President Joe Biden touted clean energy investments in hopes of garnering support ahead of the 2024 election.
Winston & Strawn LLP
On April 17, 2024, the Supreme Court of the United States held that employees alleging they were subjected to discriminatory job transfers under Title VII need only show that they suffered some harm...
Seyfarth Shaw LLP
The Supreme Court recently took away an often-used weapon by shareholder plaintiffs in securities fraud cases, ruling that "pure omissions" from periodic SEC filings (absent any other duty to disclose) are not actionable under SEC Rule 10b-5.
Vorys Sater Seymour & Pease
On Friday, April 19, 2024, Pennsylvania's Office of Development Programs (ODP) provided public notice of the new fee schedule rates for services provided...
Quinn Emanuel Urquhart & Sullivan
In the summer of 2022, the Boston Volunteer Lawyers Project (VLP) asked if the firm could represent a family of four facing eviction in just three weeks' time on a pro bono basis.
Butler Snow LLP
As civil trials become more expensive and less frequent, proactive attorneys should look for ways to streamline or end their cases before trial.
Venable LLP
On April 12, 2024, the Federal Circuit dismissed CAFC Appeal No. 24-1402 and Cross-Appeal No. 24-1405 for lack of jurisdiction following its February 22, 2024 order directing Regeneron and Mylan / Biocon.
K&L Gates
For both consumers and producers, the recent seismic shifts in packaging—from materials to circularity advertising—have been hard to miss. The past few years have introduced several state laws...
WilmerHale
"We strive at WilmerHale to give younger lawyers the same opportunities, in terms of training and learning, that we who have been here for a long time had ourselves...
Lewis Brisbois Bisgaard & Smith LLP
Recent years have seen multiple court rulings addressing whether certain allegedly discriminatory and retaliatory actions by employers that do not cause significant harm to the employee can nevertheless be the subject of a viable claim under Title VII of the Civil Rights Act of 1964 as amended.
Foley & Lardner
On April 12, 2024, the United States Supreme Court delivered an important decision on the issue of whether a failure to make disclosure required under Item 303 of Regulation S-K can support a Rule 10b-5 claim...
Jones Day
The United States Supreme Court in Macquarie Infrastructure Corp. v. Moab Partners, L.P., No. 22-1165, ruled that a corporation is not liable under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 ...
Quinn Emanuel Urquhart & Sullivan
The firm represented defendants Tilray Brands, Inc. and High Park Holdings Ltd. in a licensing dispute against Docklight Brands, Inc. involving cannabis products sold under the Bob Marley brand.
Quinn Emanuel Urquhart & Sullivan
Legal professional privilege is a longstanding and fundamental principle of English law, and yet it finds itself before the Courts with such frequency that it is also one that is continually evolving.
Foley Hoag LLP
On April 17, 2024, the Supreme Court issued a unanimous decision in Muldrow v. St. Louis that rejected a heightened injury standard for Title VII claims based on job transfers...
Crowell & Moring LLP
On April 12, 2024, the Tenth Circuit issued a decision in I DIG Texas LLC v. Kerry Creager, which analyzed country-of-origin claims in a manner that diverged from the well-established Federal Trade Commission's "Made in USA" policy.
Goodwin Procter LLP
As we previously reported, trial in Regeneron Pharmaceutical, Inc.'s BPCIA case against Mylan Pharmaceuticals Inc. and Biocon Biologics, Inc. (collectively, "the Biocon Defendants")...
Quinn Emanuel Urquhart & Sullivan
Legal professional privilege is a longstanding and fundamental principle of English law, and yet it finds itself before the Courts with such frequency that it is also one that is continually evolving.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media